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The implementation of infectionmodels that approximate human disease is essential for understanding pathogenesis at the mo-
lecular level and for testing new therapies before they are entered into clinical stages. Insects are increasingly being used as sur-
rogate hosts because they share, with mammals, essential aspects of the innate immune response to infections. We examined
whether the larva of the wax mothGalleria mellonella could be used as a host model to conceptually approximate Klebsiella
pneumoniae-triggered pneumonia. We report that the G. mellonellamodel is capable of distinguishing between pathogenic and
nonpathogenic Klebsiella strains. Moreover, K. pneumoniae infection of G. mellonellamodels some of the known features of
Klebsiella-induced pneumonia, i.e., cell death associated with bacterial replication, avoidance of phagocytosis by phagocytes, and
the attenuation of host defense responses, chiefly the production of antimicrobial factors. Similar to the case for the mouse
pneumonia model, activation of innate responses improved G. mellonella survival against subsequent Klebsiella challenge. Viru-
lence factors necessary in the mouse pneumonia model were also implicated in theGalleriamodel. We found that mutants lack-
ing capsule polysaccharide, lipid A decorations, or the outer membrane proteins OmpA and OmpK36 were attenuated inGalle-
ria. All mutants activated G. mellonella defensive responses. The Galleriamodel also allowed us to monitor Klebsiella gene
expression. The expression levels of cps and the loci implicated in lipid A remodeling peaked during the first hours postinfection,
in a PhoPQ- and PmrAB-governed process. Taken together, these results support the utility of G. mellonella as a surrogate host
for assessing infections with K. pneumoniae.
In 1890, Robert Koch formulated Koch’s postulates as generalguidelines for identifying disease-causing organisms. One cen-
tury later, Stanley Falkow established the molecular version of
Koch’s postulates, this time to guide the identification of micro-
bial genes encoding virulence factors. One of the key points of the
molecular postulates is to test the virulence of a microorganism
with an inactivated candidate virulence gene in an appropriate
animal model. Therefore, the use of animal models to identify the
virulence factors of human pathogens is indispensable. Currently,
identification and characterization of novel virulence factors rely
largely on assessing mutant bacteria for growth in the organs of
infected mice. The dependence on mouse infection models limits
large-scale analysis of virulence due to the large number of ani-
mals needed to obtain statistically significant results.
To circumvent these issues, the search for alternative host
models is ongoing. Ideally, these alternative models should be easy
to maintain and infect, should be amenable to genetic manipula-
tion, and should model aspects of vertebrate defenses upon infec-
tion, chiefly the immune response. The immune defense consists
of two main parts, an innate and an adaptive response, with the
latter being delayed but highly specific and long lasting. However,
because adaptive immune responses have appeared in the ances-
tors of cartilaginous fish, most alternative host models reflect only
features of the interplay between the innate immune system and
the pathogen. Although this is certainly a limitation, it should be
noted that the innate immune system is responsible for the early
clearance of most infections and also shapes adaptive immune
responses (1). In any case, these models will be useful only if the
pathogens employ the same virulence factors in the infection pro-
cess regardless of host.
Drosophila melanogaster, Caenorhabditis elegans, and the fish
Danio rerio have been used widely to model host-pathogen inter-
actions. In only a few cases, however, have findings obtained in
these models been validated using vertebrate hosts (mice) (2–10).
A common caveat of these models is that the optimal temperature
for maintaining them is below 28°C, whereas the optimum tem-
perature for most human pathogens is 37°C. Since virulence gene
expression is frequently regulated by temperature, it is likely that
temperature requirements bias gene expression and affect the
pathogen response to these hosts. The larva of the wax moth Gal-
leria mellonella is emerging as a reliable model host for studying
the pathogenesis of many human pathogens because, among
other advantages, G. mellonella can grow at 37°C (11–18). How-
ever, there is a paucity of information on the extent to which the
infection of G. mellonella can mimic the interplay between the
innate immune system and human pathogens.
The present study was initiated to determine whether G. mel-
lonella could be used as a host model to conceptually approximate
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a human disease, Klebsiella pneumoniae-triggered pneumonia. K.
pneumoniae is an important cause of community-acquired pneu-
monia in individuals with impaired pulmonary defenses and is a
major pathogen in nosocomial pneumonia (19, 20). Results ob-
tained using the mouse model of Klebsiella pneumonia highlight
the fact that the clearance of the pathogen is primarily dependent
upon a vigorous innate immune response (21–28). Furthermore,
stimulation of this response enhances bacterial clearance and pro-
longs animal survival (29–32). Conversely, this suggests that K.
pneumoniae tries to counteract the induction of these host defense
responses. Indeed, we and others have shown that, in sharp
contrast to wild-type strains, attenuated mutant strains acti-
vate an inflammatory program, ultimately favoring their clear-
ance (33–37).
Here we present data indicating that the G. mellonella model
replicates features of K. pneumoniae infection biology, including
the protection induced by stimulation of host immunity. We also
report that the G. mellonella model is useful for assessing the
pathogenic potential of K. pneumoniae, as we observed a strong
correlation with the virulence previously determined in the mouse
pneumonia model of infection.
MATERIALS AND METHODS
Ethics statement. Mice were treated in accordance with the Directive of
the European Parliament and of the Council on the Protection of Animals
Used for Scientific Purposes (directive 2010/63/EU) and in agreement
with the Bioethical Committee of the University of the Balearic Islands.
This study was approved by the Bioethical Committee of the University of
the Balearic Islands, under authorization number 1748.
Bacterial strains and growth conditions. Bacterial strains and
plasmids used in this study are listed in Table 1. Strains were grown in
lysogeny broth (LB) at 37°C on an orbital shaker (180 rpm). When appro-
priate, antibiotics were added to the growth medium at the following
concentrations: rifampin (Rif), 50 g/ml; ampicillin (Amp), 100 g/ml;
and kanamycin (Km), 100 g/ml.
G. mellonella larvae.G. mellonella larvae were acquired from Alcotán
Valencia SLU and kept at 21°C in darkness with a nonrestricted diet. It has
been reported that food deprivation ofG.mellonella larvae leads to reduc-
tions in cellular and immune responses (38). Larvae were used within 12
TABLE 1 Bacterial strains and plasmids used in this study





DH10B F endA1 recA1 galE15 galK16 nupG rpsL lacX74 80dlacZM15 araD139 (ara,leu)7697 mcrA
(mrr-hsdRMS-mcrBC) 
Invitrogen
MG1655 F  ilvG rfb-50 rph-1 Laboratory collection
Klebsiella aerogenes Laboratory collection
Klebsiella pneumoniae strains
MGH78578 Clinical isolate (serotype O?:K52) Laboratory collection
43816 Clinical isolate (serotype O1:K2) ATCC
NTUH-K2044 Clinical isolate (serotype O1:K1) 64, 65
52145 Clinical isolate (serotype O1:K2); Rifr 51, 66
USA1850 Clinical isolate 47, 48
2330 Clinical isolate 47, 48
2073 Clinical isolate 47, 48
43816 manC 43816 manC; Kmr; the manC gene of the wca gene cluster was inactivated; no CPS expression Unpublished data
52145 wcaK2 52145 manC; Rif
r; the manC gene of the wca gene cluster was inactivated; no CPS expression 44
52145 pmrF 52145 pmrF; Rifr; the pmrF gene was inactivated 56
52145 lpxO 52145 lpxO; Rifr; the lpxO gene was inactivated Unpublished data
52145 pagPGB 52145 pagP::Km-GenBlock; Rifr Kmr; the pagP gene was inactivated 56
52145 pagPGB pmrF 52145 pmrF pagP::Km-GenBlock; Rifr Kmr; the pagP and pmrF genes were inactivated 36
52OmpA2 52145 ompA; Rift Cmr; the ompA gene was inactivated 56
52OmpK36 52145 ompK36; Rift Cmr; the ompK36 gene was inactivated 56
52145 phoQGB 52145 phoQ::Km-GenBlock; Rifr Kmr; the phoQ gene was inactivated 56
52145 pmrAB 52145 pmrAB; Rifr; the pmrAB genes were inactivated 56
52145 pmrAB phoQGB 52145 pmrAB phoQ::Km-GenBlock; Rifr Kmr; the phoQ and pmrAB genes were inactivated 56
52145 rcsB 52145 rcsB; Rifr; the rcsB gene was inactivated 56
Plasmids
pGPL01 Firefly luciferase transcriptional fusion suicide vector; Ampr 46
pGPLKpnCps pGPL01 containing cps promoter region; Ampr 56
pGPLKpnPmrH pGPL01 containing pmrH promoter region; Ampr 56
pGPLKpnPagP pGPL01 containing pagP promoter region; Ampr 56
pGPLKpnLpxO pGPL01 containing lpxO promoter region; Ampr Unpublished data
pGPLKpnPhoP pGPL01 containing phoP promoter region; Ampr 56
pGPLKpnYojN pGPL01 containing yojN promoter region; Ampr 56
pGPLKpnRcsC pGPL01 containing rcsC promoter region; Ampr 56
pGPLKpnPmrC pGPL01 containing pmrC promoter region; Ampr This study
pFPV 25.1 rpsM::gfpmut3; Ampr 41
a Cmr, chloramphenicol resistance; Rifr, rifampin resistance; Kmr, kanamycin resistance; Ampr, ampicillin resistance. The wcaK2 gene is manC.
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days of receipt. Larvae of approximately 250 to 350 mg were selected for
the experiments.
Infection of G. mellonella larvae. Bacteria were grown in 5 ml LB,
harvested during exponential phase (2,500  g, 20 min, 24°C), and
washed once with 10 mM phosphate-buffered saline (PBS; pH 6.5). Bac-
teria were diluted in PBS to an optical density at 600 nm (OD600) of 1,
which corresponds to approximately 1 109 CFU/ml. After surface dis-
infection using ethanol (70% [vol/vol]), larvae were injected with 10l of
bacterial suspension, containing approximately 1 108 CFU/ml, into the
last right proleg by use of a Hamilton syringe with a 30-gauge needle. A
group of 10 larvae were injected with 10l of PBS in parallel to ensure that
death was not due to injection trauma. Larvae were placed in 9.2-cm petri
dishes with food and kept at 37°C in the dark. Insects were considered
dead when they did not respond to physical stimuli. Larvae were exam-
ined for pigmentation, and time of death was recorded. Assays were al-
lowed to proceed for only 3 days, as pupa formation could occasionally be
seen by day 4. At least three independent experiments were performed.
For 50% lethal dose (LD50) experiments, a series of 10-fold serial di-
lutions containing 104 to 107 CFU in PBS were injected into G. mellonella
larvae. Ten larvae were injected at each dilution. For each strain, data from
three independent experiments were combined, and LD50s were calcu-
lated according to the formula of Reed and Muench (39). Results are
expressed as log LD50.
Determination of in vivo bacterial loads. Insects were infected with
approximately 1  106 CFU per larva of K. pneumoniae 52145 or 52145
wcaK2. Groups of three insects were collected at different postinfection
time points (5, 10, and 24 h), and their surfaces were disinfected with
ethanol. The three larvae were homogenized in 2 ml of PBS by use of an
Ultra-Turrax T10 Basic homogenizer (IKA). Serial dilutions of the ho-
mogenate in PBS were plated on LB agar supplemented with rifampin,
and colonies were counted after incubation at 37°C for 24 h. At least three
independent experiments were performed. No CFU were recovered from
noninfected larvae in LB agar supplemented with rifampin.
PO activity assay. Insects were infected with approximately 1  106
CFU ofK. pneumoniae 52145 or 52145wcaK2 per larva. At different time
points postinfection (5, 10, and 24 h), insects were surface sterilized with
ethanol, immobilized in a sterile petri dish, and dissected at the last
metamere. From each larva, 15 l of the outflowing hemolymph was
immediately collected in a sterile ice-cold microcentrifuge tube contain-
ing 10 l of a saturated solution of N-phenylthiourea (Sigma) in distilled
water to prevent melanization. Hemolymph samples from three larvae
were pooled. Cells and debris were removed by centrifugation at 4,000
g for 10 min at 4°C, and supernatants were diluted at a 3:1 (vol/vol) ratio
with 50 mM PBS (pH 6.5). The phenoloxidase (PO) activity in the plasma
was quantified using a microplate enzyme assay as described previously
(40). Briefly, a reaction mixture containing 115 l 50 mM PBS (pH 6.5),
10l diluted hemolymph plasma, and 2l of Escherichia coli lipopolysac-
charide (LPS) (5 mg/ml; Sigma) was left for 1 h at room temperature to
allow the activation of the enzyme. Twenty-five microliters of 20 mM
4-methyl catechol (Sigma) was then added to initiate the reaction, and the
final volume was made up to 200l with sterile distilled water. Changes in
absorbance at 490 nm were monitored at room temperature, with a read-
ing taken every 5 min for 1 h, using a PowerWave HT microplate spectro-
photometer (Biotek). The experiment was performed in triplicate and
independently repeated at least three times. Phenoloxidase activity is ex-
pressed as the mean OD490/min.
Hemocyte quantification and viability staining.Larvae were infected
with 1 106 CFU of K. pneumoniae 52145 or 52145 wcaK2, and hemo-
lymph was collected at 5, 12, and 24 h postinfection. Hemolymph samples
from three larvae were pooled in a microcentrifuge tube containing 10 l
of a saturated solution ofN-phenylthiourea (Sigma) in distilled water, and
hemocytes were recovered by centrifugation (1,500  g for 3 min). He-
mocytes were resuspended in 50 l of trypan blue (0.02% [vol/vol] in
PBS). Samples were incubated at room temperature for 10 min, and viable
hemocytes were enumerated using a Neubauer hemocytometer. Each
sample was analyzed in triplicate. The averages for three independent
experiments were plotted graphically.
Immunofluorescence assay with extracted hemocytes. Insects were
infected with approximately 1  106 CFU per larva of K. pneumoniae
52145 or 52145 wcaK2 carrying pFPV25.1. This plasmid expresses gfp-
mut3 under the control of the Salmonella rpsM promoter. This fusion has
been reported to be expressed at similar levels in various environments,
including growth media and mammalian cells (41, 42). At different time
points postinfection (5, 12, and 24 h), the hemolymph samples from three
infected larvae were collected, pooled in a microcentrifuge tube contain-
ing 10 l of a saturated solution of N-phenylthiourea (Sigma) in distilled
water, and diluted with 150 l of PBS. Samples were seeded on poly-L-
lysine-coated 12-mm circular coverslips in 24-well tissue culture plates.
Plates were centrifuged at 200 g for 5 min and incubated at 37°C for
2 h to allow attachment of hemocytes. Coverslips were washed twice
with PBS, fixed with 400 l of 4% paraformaldehyde for 20 min at
room temperature, washed three times with PBS, and quenched with
14 mM ammonium chloride. Extracellular bacteria were stained with
rabbit anti-K. pneumoniae polyclonal serum (1:5,000) followed by
donkey anti-rabbit rhodamine red X-conjugated antibody (1:200)
(Jackson ImmunoResearch Laboratories, Inc.). After permeabilization
of the cells with 0.1% saponin in PBS, DNA was stained with Hoechst
dye (1:2,500). Coverslips were mounted on Aqua Poly/Mount medium
(Polysciences), and immunofluorescence was analyzed with a Leica
CTR6000 fluorescence microscope.
Radial diffusion bioassay. To detect the activity of antimicrobial fac-
tors in the hemolymph of infected larvae, we used a previously described
bioassay of growth inhibition zones (43, 44), with minor modifications.
Briefly, an underlay gel that contained 1% (wt/vol) agarose of low electro-
endosmosis (agarose D1 low EEO; Pronadisa), 2 mM HEPES (pH 7.2),
and 0.3 mg tryptone soy broth (TSB; Oxoid) powder per ml was equili-
brated at 50°C and then inoculated with E. coli DH10B to a final concen-
tration of 5  105 CFU per ml of molten gel. This gel was poured into
standard square petri dishes (10 10 1.5 cm), and after solidification,
small wells with a 15-l capacity were carved out. Hemolymph samples
from three larvae infected with 1 106 CFU of Klebsiella or heat-killed E.
coli MG1655 were collected and pooled in an ice-cold microcentrifuge
tube containing 10 l of a saturated solution of N-phenylthiourea
(Sigma). Wells were filled with 10-l aliquots of these samples, and the
agar plates were incubated for 3 h at 37°C. After that, a 30-ml overlay gel
composed of 1% agarose and 6% TSB powder in water was poured on top
of the previous gel, and the plates were incubated at 37°C. After 18 h, the
diameters of the inhibition halos were measured to the nearest 1 mm and,
after subtraction of the diameter of the well, were expressed in inhibition
units (10 units  1 mm). PBS and 32 g/ml polymyxin B (Sigma) were
used as negative and positive controls, respectively, in the bioassay. All
measurements were done in duplicate on at least five separate occasions.
Antimicrobial peptide resistance assay. Insects were infected with
approximately 1 106 heat-killed (65°C for 15 min) E. coli MG1655 cells
per larva to increase the levels of antimicrobial factors in the hemolymph
(45). After 24 h, hemolymph samples from three larvae were collected and
pooled in an ice-cold microcentrifuge tube containing 10l of a saturated
solution of N-phenylthiourea (Sigma). Fifty microliters of PBS was added
to each mixture, and then 25 l of diluted sample was mixed with 5 l of
a Klebsiella suspension containing 105 CFU per ml, prepared in 10 mM
PBS (pH 6.5), 1% TSB, and 100 mM NaCl. The mixtures were incubated
at 37°C for 3 h. Serial dilutions of the samples in PBS were plated on LB
agar supplemented with rifampin, and colonies were counted after incu-
bation at 37°C for 24 h. Results are expressed as percentages of the number
of bacteria not exposed to antibacterial agents. All measurements were
done in triplicate on three separate occasions.
RNA extraction and RT-PCR. Larvae were infected with approxi-
mately 1 106 CFU, and after 8 h, individual insects were homogenized
on ice with 1 ml of Tri reagent (Ambion), using an Ultra-Turrax T10 Basic
homogenizer (IKA). Total RNA was purified first by using a standard
Insua et al.
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chloroform-isopropyl alcohol protocol, and the obtained RNA was fur-
ther purified using a Nucleospin RNAII kit (Macherey-Nagel) that in-
cluded one step of on-column DNase treatment, following the manufac-
turer’s instructions. cDNA was obtained by retrotranscription of 1.5 to 2
g total RNA by use of a commercial Moloney murine leukemia virus
(M-MLV) reverse transcriptase (Sigma). A mix (1:1) of an oligo(dT)18
primer and random hexamer primers (Thermo Scientific) was used. Real-
time PCR (RT-PCR) analyses were performed with a Smart Cycler real-
time PCR instrument (Cepheid, Sunnyvale, CA).
Fifty nanograms of cDNA was used as the template in a 25-l reaction
mixture containing KapaSYBR Fast qPCR mix (Kapa Biosystems) and
primer mix. Actin and 18S rRNA genes were amplified as housekeeping
genes. The primers used are listed in Table S1 in the supplemental mate-
rial. The thermocycling protocol was as follows: 95°C for 3 min for hot-
start polymerase activation, followed by 45 cycles of denaturation at 95°C
for 15 s and annealing at 60°C for 30 s. SYBR green dye fluorescence was
measured at 521 nm during the annealing phase. Relative quantities of
mRNAs were obtained using the comparative threshold cycle (CT)
method, with normalization to the 18S rRNA and actin genes.
Construction of pmrC::lucFF reporter fusion. A 445-bp DNA frag-
ment containing the promoter region of the pmrCAB operon was ampli-
fied by PCR using Vent polymerase, digested with EcoRI, gel purified, and
cloned into EcoRI-SmaI-digested pGPL01 suicide vector (46). This vector
contains a promoterless firefly luciferase gene (lucFF) and an R6K origin
of replication. A plasmid in which lucFF was under the control of the
pmrCAB promoter region was identified by restriction digestion analysis
and named pGPLKpnPmrC. This plasmid was introduced into E. coli
SY327-pir, from which it was mobilized into K. pneumoniae 52145 by
triparental conjugation using the helper strain E. coli HB101/pRK2013.
One strain in which the suicide vector was integrated into the genome
by homologous recombination was selected. This was confirmed by
Southern blotting and a PCR using primers CheckProkpnpmrCF and
ChecklucFFR (data not shown).
In vivo monitoring of gene expression during G. mellonella infec-
tion. Insects were infected with approximately 1  106 CFU K. pneu-
moniae carrying a lucFF-based transcriptional fusion per larva (Table 1).
At the indicated time points, hemolymph samples from individual larvae
(approximately 20l) were collected in microcentrifuge tubes containing
10 l of a saturated solution of N-phenylthiourea (Sigma) and kept at
room temperature. Five larvae were infected per time point. Ten microli-
ters of sample was serially diluted in PBS and then plated on LB agar with
rifampin to determine the number of CFU present in the hemolymph.
Twenty microliters of mixture was diluted with 100 l of PBS and mixed
with 100 l of luciferase assay reagent (1 mM D-luciferin [Synchem] in
100 mM citrate buffer, pH 5), and luminescence was immediately mea-
sured with a model LB9507 luminometer (Berthold) and expressed as
relative light units (RLU). Control experiments showed that hemolymph
did not quench luminescence. The luminescence levels of lucFF-express-
ing Klebsiella cells from culture did not change after mixing the bacteria
with hemolymph extracted from infected larvae (at 18 h postinfection).
Luminescence was also determined from the inoculum by mixing a
100-l aliquot of the bacterial suspension with 100 l of luciferase assay
reagent.
Intranasal infection model. Five- to 7-week-old female C57BL/
6JOlaHsd mice (Harlan) were anesthetized by intraperitoneal (i.p.) injec-
tion with a mixture containing ketamine (50 mg/kg of body weight) and
xylazine (5 mg/kg). Overnight bacterial cultures were centrifuged (2,500 g,
20 min, 22°C), resuspended in PBS, and adjusted to 5 104 CFU/ml for
determination of bacterial loads. Twenty microliters of the bacterial sus-
pension was inoculated intranasally in four 5-l aliquots. Noninfected
mice were inoculated intranasally with 20 l of PBS in four 5-l aliquots.
To facilitate consistent inoculations, mice were held vertically during in-
oculation and placed on a 45° incline while recovering from anesthesia. At
the indicated times after infection, mice were euthanized by cervical dis-
location, and lungs were rapidly dissected for bacterial load determina-
tion.
Dissected lungs were homogenized on ice in 500l of PBS by use of an
Ultra-Turrax TIO Basic homogenizer (IKA). Bacteria from the homoge-
nates and serial dilutions thereof were recovered on LB agar plates con-
taining rifampin. Results are reported as log CFU per gram of tissue.
Statistical methods. Statistical analyses were performed using one-
way analysis of variance (ANOVA) with Bonferroni contrasts or the one-
tailed t test or, when the requirements were not met, by the Mann-Whit-
ney U test. P values of0.05 were considered statistically significant. The
analyses were performed using Prism4 for PC (GraphPad Software).
RESULTS
K. pneumoniae infection causes death of G. mellonella larvae.
We examined the susceptibility of G. mellonella to K. pneumoniae
strain 52145 (O1:K2 serotype) (Table 1), which is used in molec-
ular pathogenesis studies. Larvae were injected with 106 CFU, and
their survival was monitored (Fig. 1A). K. pneumoniae 52145
caused a time-dependent death of all larvae; at 24 h postinfection,
75% of the larvae were dead, and the remaining survivors were
dead at 72 h postinfection. No mortality was observed in the PBS-
injected G. mellonella larvae (Fig. 1A). Three additional K. pneu-
moniae strains were tested (Table 1). Strains ATCC 43816 (sero-
type O1:K2) and NTUH-K2044 (serotype O1:K1) are also
commonly used for in vivo and in vitro infection biology studies.
Larvae were injected with 106 CFU of these strains. While both
strains killed G. mellonella, strain 43816 killed 95% of the larvae
after 24 h (Fig. 1B). Finally, we infectedG.mellonellawith 106 CFU
of strain MGH78578, which is a multidrug-resistant isolate (sero-
type K52) (Table 1). MGH78578 also killed 100% of infected lar-
vae at 72 h postinfection (Fig. 1B).
To determine whether K. pneumoniae-induced lethality was
dependent on the number of injected bacteria, larvae were in-
jected with 104, 105, 106, or 107 CFU, and mortality was recorded
for up to 72 h postinfection (Fig. 1C). While infection with 107
CFU of all strains resulted in 100% G. mellonella mortality within
24 h of infection, no mortality was observed when G. mellonella
larvae were infected with 104 CFU of K. pneumoniae strain 52145,
43816, or MGH78578 (Fig. 1C). NTUH-K2044 killed 25% of the
larvae at this dose (Fig. 1C).
We next determined the LD50s of the four strains. As shown in
Table 2, NTUH-K2044 had the lowest LD50, followed by strain
43816 and then strains 52145 and MGH78578. The LD50s of K.
pneumoniae 52145 and MGH78578 were not significantly differ-
ent. Notably, three K. pneumoniae strains with reduced virulence
in mammalian models (47, 48) had LD50s significantly higher than
those of K. pneumoniae 52145 and MGH78578 (P  0.05 by the
one-sample t test) (Table 2). Moreover, a nonpathogenic labora-
tory-adapted strain ofKlebsiella had one of the highest LD50s. This
strain is used as a control strain in infections of nonmammalian
hosts (49).
Collectively, these data show thatG.mellonella is susceptible to
K. pneumoniae infection, in a dose-dependent manner.
K. pneumoniaeCPS is important forG.mellonella infection.
The capsule polysaccharide (CPS) is a well-characterized viru-
lence factor ofK. pneumoniae. CPS mutant strains are avirulent, as
they are unable to cause pneumonia or urinary tract infections
(50–52). We sought to determine the contribution of CPS to K.
pneumoniae pathogenesis inG.mellonella. Infection of larvae with
106 CFU of strain 52145 wcaK2, the isogenic cps mutant of K.
pneumoniae 52145 (Table 1), did not cause any mortality of the
K. pneumoniae Pathogenesis in G. mellonella
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larvae over the 72 h of the experiment, whereas the wild-type
strain killed all larvae within this time (Fig. 2A). An inoculum of
106 CFU of K. pneumoniae 48136 killed 100% of G. mellonella
larvae within 24 h. In contrast, the isogenic cps mutant, strain
43816 manC, killed 50% of G. mellonella larvae within this time
(Fig. 2A). The LD50s of the cps mutants, i.e., strains 52145 wcaK2
and 43816 manC (6.97 	 0.24 and 5.67 	 0.03, respectively),
were significantly higher than those of the isogenic wild-type
strains, K. pneumoniae 52145 and 43816 (4.94	 0.11 and 4.49	
FIG 1 K. pneumoniae infection of G. mellonella induces dose-dependent lethality. (A) Larvae were injected with PBS or with 106 CFU of K. pneumoniae 52145
(Kp52145), and survival was monitored over 72 h postinfection. (B) Larvae were injected with PBS or with 106 CFU of K. pneumoniae 43816 (Kp43816),
NTUH-K2044, or MGH78578, and survival was monitored over 72 h postinfection. (C) Mortality of larvae infected with K. pneumoniae 52145, 43816,
NTUH-K2044, or MGH78578 was dose dependent.











K. aerogenes 6.00	 0.01
FIG 2 CPS is important for K. pneumoniae-induced G. mellonella lethality.
(A) Larvae were injected with 106 CFU ofK. pneumoniae 52145 or 43816 or the
cps mutant 52145 wcaK2 or 43816 manC, and survival was monitored over
72 h postinfection. (B) Three Klebsiella-infected larvae were pooled and ho-
mogenized, and numbers of CFU were determined by plating.
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0.03, respectively) (P 0.05 for comparison with the correspond-
ing wild type by the one-sample t test). The LD50 of strain 43816
manC was significantly lower than that of 52145 wcaK2 (P 
0.05 by the one-sample t test). Altogether, these findings indicated
that K. pneumoniae-induced mortality is dependent on the pres-
ence of CPS.
We sought to determine whether G. mellonella mortality is as-
sociated with the growth of Klebsiella in infected larvae. Larvae
were infected with 106 CFU of K. pneumoniae 52145 or the cps
mutant strain 52145 wcaK2. At selected time points, three larvae
were pooled and homogenized, and the number of CFU per ml
was determined. As shown in Fig. 2B, infection of G. mellonella
with the cps mutant resulted in an initial 3-fold increase of CFU at
5 h postinfection. However, this was followed by a decrease in
bacterial numbers and 99% clearance of the inoculum from the
larvae at 24 h postinfection. In contrast, infection of G. mellonella
with K. pneumoniae 52145 resulted in an increase in bacterial
numbers over time (Fig. 2B), hence demonstrating that wild-type
K. pneumoniae replicates in G. mellonella.
Interplay between G. mellonella innate immune system and
K. pneumoniae. The progress of infection of G. mellonella by
strains causing death of larvae, such as K. pneumoniae 52145, was
accompanied by an increase in pigmentation (Fig. 3A). This is
indicative of PO activity in the hemolymph (40, 53). The activity
of this enzyme results in the deposition of melanin around invad-
ing bacteria by the insect hemocytes, which wrap around the bac-
teria to form nodules, thereby isolating the pathogens (53). To
evaluate this immune response, we determined the levels of PO
activity in the hemolymph of larvae infected with K. pneumoniae
52145 (Fig. 3B). The levels of PO in PBS-infected insects remained
constant (Fig. 3B). In contrast, PO activity in insects infected with
K. pneumoniae 52145 peaked at 12 h postinfection, whereas at 5
and 24 h postinfection, PO levels in larvae infected with K. pneu-
moniae 52145 were not significantly different from those in PBS-
challenged insects (Fig. 3B). Interestingly, larvae infected with the
cps mutant presented levels of PO similar to those in PBS-injected
insects at all time points analyzed (Fig. 3B).
G. mellonella hemolymph contains hemocytes, which function
in a manner similar to that of phagocytes of mammals (45). To
further analyze the pathogen-host interaction in the insect model,
we followed the interaction between insect hemocytes and K.
pneumoniae wild-type and cps mutant strains throughout the
course of infection. To assess whetherG.mellonella hemocytes are
able to engulf K. pneumoniae, hemocytes were isolated from the
hemolymph of larvae infected with green fluorescent protein
(GFP)-expressing K. pneumoniae 52145 at 5, 12, and 24 h postin-
fection and differentially immunostained to detect intra- and ex-
tracellular bacteria (Fig. 4). We were unable to detect intracellular
bacteria at 5, 12 (Fig. 4A), or 24 h postinfection (data not shown).
In contrast, at 5 h postinfection, the GFP-expressing cps mutant
was found inside and associated with hemocytes (Fig. 4B), and by
12 h postinfection, the mutant was observed only inside hemo-
cytes (Fig. 4B). At 24 h postinfection, we could not detect any
bacteria in the samples (data not shown). Altogether, these find-
ings indicate that G.mellonella hemocytes do not engulf wild-type
K. pneumoniae.
Examination of the preparations from larvae infected with K.
pneumoniae 52145 by immunofluorescence indicated a decrease
in the overall number of hemocyte nuclei which was more evident
at 24 h postinfection (data not shown). This observation
prompted us to study whether K. pneumoniae 52145 may trigger
hemocyte depletion. Insects were infected with K. pneumoniae
52145 or injected with PBS, and hemocytes purified from the he-
molymph were counted by light microscopy at 5, 12, and 24 h
FIG 3 Characterization of G. mellonella innate responses to K. pneumoniae infection. (A) Larvae and extracted hemolymph became pigmented progressively
darker over the course of the infection, indicative of melanin production by PO. (B) PO activity in the plasmas of insects injected with PBS or infected with K.
pneumoniae 52145 or the cps mutant 52145 wcaK2 (cps) was quantified at 5, 12, and 24 h postinfection. Results represent the means and standard deviations
for three independent experiments. *, P 0.05 (results are significantly different from the results for PBS-injected larvae by the one-tailed t test).
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postinfection (Fig. 4C). The number of hemocytes decreased over
time in larvae infected with K. pneumoniae 52145, hence suggest-
ing that wild-type K. pneumoniae does indeed induce cell destruc-
tion (Fig. 4C). In contrast, the number of hemocytes was not
significantly different between the cps mutant-infected and PBS-
injected groups at all time points (Fig. 4C).
The innate immune cellular response in insects is accompanied
by secretion of antimicrobial peptides in response to either injury
or invasion by a pathogen (45). As anticipated, the hemolymph of
larvae infected with a heat-killed laboratory-adapted E. coli strain
contained antimicrobial factors which could be detected by a ra-
dial diffusion bioassay (Fig. 5A). This bioassay is typically used to
evaluate the presence and action of antimicrobial peptides in bio-
logical samples (43). The levels of antimicrobial factors in the
hemolymph of E. coli-infected larvae were higher at 24 than at 5 h
postinfection (Fig. 5A). We tested the susceptibility of K. pneu-
moniae to these E. coli-elicited antimicrobial factors. Indeed, sur-
vival assays showed that K. pneumoniae 52145 and the cps mutant
were susceptible to the antimicrobial factors present in the hemo-
lymph ofG.mellonella larvae infected with heat-killedE. coli for 24
h (53%	 12% and 39%	 12% survival, respectively; P
 0.05 by
the one-sample t test).
The radial diffusion bioassay was used to determine whetherK.
pneumoniae infection triggers the production of antimicrobial
FIG 4 Wild-type K. pneumoniae is not engulfed by G. mellonella hemocytes. (A) K. pneumoniae 52145 expressing GFP is not engulfed by hemocytes and
replicates extracellularly. External bacteria were immunostained red (TX-Red). (B) Strain 52145 wcaK2 expressing GFP is engulfed by hemocytes. External
bacteria were immunostained red. (C) Viable hemocyte concentrations were recorded at 5, 12, and 24 h postinfection. Larvae were injected with PBS or infected
with K. pneumoniae 52145 or the cps mutant 52145wcaK2 (cps). Results (means and standard deviations for three independent experiments) are expressed as
percentages of the number of hemocytes recorded for PBS-injected larvae at 5 h postinfection. *, P  0.05 (results are significantly different for the indicated
comparisons by the one-tailed t test).
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factors. As shown in Fig. 5B, the levels of antimicrobials in the
hemolymph of larvae infected with K. pneumoniae 52145 were
similar to those found in PBS-infected larvae. Moreover, these
levels were not significantly different over time (P
 0.05 for any
comparison between hemolymph from K. pneumoniae 52145-in-
fected larvae by one-way ANOVA). The lack of induction of anti-
microbial factors by K. pneumoniae 52145 was dependent on the
expression of CPS, since hemolymph from insects infected with
FIG 5 Wild-type K. pneumoniae does not upregulate the expression of G. mellonella antimicrobial peptides. (A) Larvae were infected with 106 heat-killed (65°C,
15 min) E. coli MG1655 cells, and at 5 and 24 h postinfection, hemolymph was extracted and the presence of antimicrobial factors assessed by radial diffusion
bioassay. The results, expressed as radial diffusion units (10 units 1 mm), represent means and standard deviations for at least four independent determina-
tions. *, P  0.05 (results are significantly different from the 5-h postinfection results by the one-tailed t test). (B) Presence of antimicrobial factors in the
hemolymph of larvae at different time points postinfection, determined by radial diffusion bioassay. Larvae were injected with PBS or infected with K.
pneumoniae 52415, heat-killed (65°C, 15 min)K. pneumoniae 52145, UV-killed (UV irradiated at 1 J for 10 min in a Bio-Link BLX cross-linker [Vilber Lourmat])
K. pneumoniae 52145, or the cps mutant strain 52145 wcaK2 (cps). The results, expressed as radial diffusion units (10 units  1 mm), represent means and
standard deviations for five independent determinations. *, P 0.05 (results are significantly different for the indicated comparisons by the one-tailed t test). (C)
Transcriptional activation of immune-responsive genes following infection. The transcription levels of lysozyme, galiomycin, gallerimycin, cecropin, and IMPI
were determined by RT-qPCR and are shown relative to the expression levels in PBS-injected animals. Larvae (five per group) were injected with PBS or infected
withK. pneumoniae 52415, heat-killed (65°C, 15 min)K. pneumoniae 52145, or the cpsmutant 52145wcaK2 (cps), and after 8 h, total RNA was purified. Results
represent means and standard deviations. *, P  0.05 (results are significantly different from the results for K. pneumoniae 52145-injected larvae by one-way
ANOVA);o, results are significantly different from the results for 52145wcaK2-injected larvae by one-way ANOVA; n.s.,P
 0.05 for the indicated comparison.
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the cps mutant presented significantly higher levels of antimicro-
bial factors than those obtained from K. pneumoniae 52145-in-
fected larvae (Fig. 5B). This was true at all time points analyzed
postinfection (Fig. 5B). However, the mere presence of CPS was
not enough to prevent the induction of antimicrobial factors, be-
cause the levels of factors found in the hemolymph of heat-killed
K. pneumoniae 52145- or UV-killed K. pneumoniae 52145-chal-
lenged larvae were not significantly different from those obtained
from insects infected with the cps mutant (Fig. 5B).
We sought to determine whether there is a correlation between
the levels of antimicrobial effectors found in the hemolymph and
the expression of antimicrobial peptides. Indeed, analysis by real-
time quantitative PCR (RT-qPCR) showed that the levels of ly-
sozyme, galiomycin, gallerimycin, cecropin, and insect metallo-
proteinase inhibitor (IMPI) were higher in insects infected with
the cps mutant than in those infected with K. pneumoniae 52145
(Fig. 5C). Only the levels of gallerimycin were significantly differ-
ent between G. mellonella larvae infected with K. pneumoniae
52145 and larvae mock infected with PBS (Fig. 5C). Notably, levels
of lysozyme, galiomycin, cecropin, and IMPI were also higher in
insects challenged with heat-killed K. pneumoniae 52145 than in
larvae infected with K. pneumoniae 52145 (Fig. 5C). Except for
lysozyme, no significant differences were found between the levels
of the peptides induced by the cpsmutant and heat-killedK. pneu-
moniae 52145 (Fig. 5C). Collectively, these findings support the
notion that wild-type K. pneumoniae does not induce the expres-
sion of antimicrobial peptides.
Activation of immunity in G. mellonella enhances the host
defense against K. pneumoniae infection. The fact that K. pneu-
moniae 52145 was susceptible to the antimicrobial factors present
in the hemolymph of E. coli-infected insects led us to analyze
whether prior induction of immune responses in G. mellonella
would protect against a subsequent infection by K. pneumoniae.
Larvae were inoculated with 106 heat-killed E. coli cells and, after
24 h, challenged with 10 times the LD50 ofK. pneumoniae 52145.E.
coli-mediated induction of immune responses provided protec-
tion against subsequent infection by a lethal dose of K. pneu-
moniae 52145 (Fig. 6A). This was also true when insects were
challenged with the more virulent strain K. pneumoniae 43816
(Fig. 6B). In preimmunized larvae, the LD50s of K. pneumoniae
52145 and 43816 were 7.00 	 0.01 and 6.80	 0.02, respectively,
which are 100-fold higher than those obtained with nonpreimmu-
nized insects.
Analysis of virulence factors necessary for K. pneumoniae
pathogenesis in G. mellonella. Having established that CPS is
necessary for K. pneumoniae virulence in G. mellonella, we sought
to determine whether other K. pneumoniae virulence factors nec-
essary for virulence in the mouse pneumonia model are also im-
portant for pathogenesis inG.mellonella. We recently showed that
K. pneumoniae LPS lipid A is decorated with palmitate and ami-
noarabinose (54). The gene encoding the acyltransferase (pagP) is
required for the addition of palmitate to lipid A (54), whereas the
pmrHFIJKLM (arnBCADTEF; referred to here as the pmrF
operon) loci are required for the synthesis and addition of amino-
arabinose to lipid A (54). Strains 52145 pmrF, 52145 pagPGB,
and 52145 pmrF pagPGB are mutant strains lacking lipid A
species containing aminoarabinose, palmitate, and both, respec-
tively (54). These mutants express the same levels of CPS as the
wild type and are attenuated in the mouse pneumonia model (54).
To evaluate whether these modifications are necessary for K.
pneumoniae pathogenesis in G. mellonella, we determined the
LD50s of the three lipid A mutants (Table 3). The LD50s of the
FIG 6 Effects of G. mellonella preimmune activation on subsequent infection with K. pneumoniae. Larvae were infected with 106 heat-killed (65°C, 15 min) E.
coli MG1655 cells and, after 24 h, infected with 10 times the LD50 of K. pneumoniae 52145 (A) or K. pneumoniae 43816 (B). Survival was monitored over 72 h
postinfection. Œ, preimmunized larvae infected with K. pneumoniae 52145; , nonpreimmunized larvae infected with K. pneumoniae 52145;, preimmunized
larvae infected with K. pneumoniae 43816; , nonpreimmunized larvae infected with K. pneumoniae 43816. Twenty larvae were infected in each experimental
group.





52145 wcaK2 6.97	 0.24*
52145 pmrF 5.74	 0.12*
52145 pagPGB 5.53	 0.06*
52145 pagPGB pmrF 5.50	 0.06*
52145 lpxO 5.61	 0.06*
52OmpA2 5.84	 0.08*
52OmpK36 6.06	 0.17*
52145 phoQGB 5.76	 0.41*
52145 pmrAB 5.80	 0.36*
52145 pmrAB phoQGB 5.75	 0.04*
52145 rcsB 5.57	 0.01*
a *, results are significantly different (P 0.05; one-tailed t test) from the results for
strain 52145.
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three mutants were higher than that of K. pneumoniae 52145 but
lower than that of the cps mutant (Table 3). No significant differ-
ences were found between the three lipid A mutants.
OmpA and OmpK36 are the most abundant outer membrane
proteins (OMPs) on the K. pneumoniae outer membrane (55).
Previously, we showed that ompA and ompK36 mutants express
levels of CPS similar to that in K. pneumoniae 52145 and that they
are attenuated in the mouse pneumonia model (33, 36, 56). Like
those of the lipid A mutants, the LD50s of the OMP mutants were
higher than that of the wild type (Table 3).
In summary, these results demonstrate a strong correlation
between findings obtained using the mouse model of pneumonia
and the G. mellonella model. To add further evidence to this no-
tion, we determined the virulence of an lpxO mutant. LpxO is the
enzyme responsible for the 2-hydroxyacyl-modified lipid A found
in K. pneumoniae (unpublished data). The virulence of this factor
has not been assessed previously. The LD50 of the lpxOmutant was
5-fold higher than that of K. pneumoniae 52145 (Table 3). To
evaluate the ability of this mutant to cause pneumonia, C57BL/
6JOlaHsd mice were infected intranasally, and at 24 and 96 h
postinfection, bacterial loads in trachea and lung homogenates
were determined (Fig. 7). At 24 h postinfection, K. pneumoniae
52145 and the lpxO mutant colonized the trachea and lungs, al-
though bacterial loads of the mutant strain were lower than those
of the wild type in both organs (Fig. 7A). Similar results were
observed at 96 h postinfection (Fig. 7B). Together, these results
further highlight that the G. mellonella model is useful for assess-
ing the pathogenic potential of K. pneumoniae.
To determine whether attenuated mutants activateGalleriade-
fense responses, we quantified the levels of antimicrobial factors in
the hemolymph of infected larvae. The levels of antimicrobials in
the hemolymph of larvae infected with the mutants were signifi-
cantly higher than those found in K. pneumoniae 52145-infected
larvae (see Fig. S1 in the supplemental material).
In vivomonitoring ofK. pneumoniae virulence gene expres-
sion during G. mellonella infection. The finding that the cps and
lipid A mutants were attenuated in G. mellonella led us to analyze
whether the environment encountered by K. pneumoniae within
the hemolymph affects the expression of the cps operon, the pmrF
operon, pagP, or lpxO. We utilized chromosomally integrated
promoter fusions to a lucFF reporter system to monitor expres-
sion from gene promoters in K. pneumoniae 52145 during infec-
tion ofG.mellonella at different time points. Data are presented as
fold increases over the results for the inocula (Fig. 8). The expres-
sion of cps::lucFF was higher in the hemolymph of larvae than in
culture medium (Fig. 8A). However, expression decreased over
time in infected larvae and was 2-fold lower at 12 h postinfection
than at 5 h postinfection (Fig. 8A). The expression of pmrH::lucFF
peaked at 5 h postinfection in the infected larvae (Fig. 8B),
whereas the pagP::lucFF fusion levels decreased over time in the
infected larvae (Fig. 8C). The levels of the lpxO transcriptional
fusion were 6-fold higher in the hemolymph than in culture me-
dium at 1 h postinfection (Fig. 8D), and the expression of the
fusion was nearly undetectable at 12 h postinfection. The reduced
expression of all transcriptional fusions over time was not due to
changes in bacterial growth in the infected larvae, since the strains
harboring the tested fusions replicated to the same levels as K.
pneumoniae 52145 in G. mellonella (data not shown).
We recently showed that PhoPQ, PmrAB, and Rcs systems
govern the expression of cps and of the loci implicated in lipid A
remodeling (54; our unpublished data). To define the contribu-
tions of these systems to the expression of the cps operon, the pmrF
operon, lpxO, and pagP in G. mellonella, we investigated the tran-
scription of these loci in isogenic mutants upon G. mellonella in-
fection. The levels of the cps transcriptional fusion were lower in
the 52145 phoQGB and 52145 pmrAB backgrounds than in K.
pneumoniae 52145 (Fig. 8E) and were nearly abolished in the
phoQ-pmrAB double mutant. In contrast, the levels obtained in
the 52145 rcsB background were similar to those found in K.
pneumoniae 52145 (Fig. 8E). The expression of the pmrH tran-
scriptional fusion was not affected in the phoQ, pmrAB, and rcsB
mutant backgrounds, but it was shut off in the phoQ-pmrAB dou-
ble mutant (Fig. 8F). PhoPQ governs the expression of pagP and
lpxO in vivo, since the levels of the transcriptional fusions were
affected only in the phoQ mutant backgrounds (Fig. 8G and H).
The facts that the expression levels found in the pmrAB back-
ground were not different from those found in the wild type and
the expression levels of both loci were not significantly different in
the phoQ and phoQ-pmrAB double mutant backgrounds are con-
sistent with the notion that PmrAB does not control the expres-
sion of pagP and lpxO in the hemolymph of infected larvae.
On the whole, these data indicate that PhoPQ and PmrAB are
necessary for cps and pmrH expression in Galleria, whereas the
expression of pagP and lpxO is controlled by PhoPQ. Interestingly,
the expression of the regulators is also affected by the environment
found within the hemolymph (see Fig. S2 in the supplemental
FIG 7 Virulence of lpxO mutant in mice. Bacterial counts in mouse organs at 24 h postinfection (A) or 96 h postinfection (B) are shown. Mice were infected
intranasally with a bacterial mixture containing 5 104 bacteria of the wild-type (K. pneumoniae 52145; ) or lpxOmutant (52145lpxO; Œ) strain. Results are
reported as log CFU per gram of tissue. *, results are significantly different (P 0.05; one-tailed t test) from the results for K. pneumoniae 52145.
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material). The expression of phoP::lucFF peaked at 1 h postinfec-
tion in the infected larvae, whereas the pmrC::lucFF fusion levels
decreased over time in the infected larvae (see Fig. S2). To monitor
transcription of the Rcs system, we analyzed the expression of
rcsD::lucFF and rcsC::lucFF transcriptional fusions. The expres-
sion of both fusions was similar in the hemolymph of larvae and in
culture medium, and moreover, it did not change over time in the
infected insects (see Fig. S2).
Finally, we determined the LD50s of phoQ, pmrAB, phoQ-pm-
rAB, and rcsBmutants. The LD50s of the four mutants were higher
than that of the wild type (Table 3).
DISCUSSION
The implementation of infection models that approximate hu-
man disease is essential not only for understanding pathogenesis
at the molecular level but also for testing new therapies before they
are entered into clinical stages. While the infection of higher ani-
mals, including knockout animals, has provided invaluable infor-
mation, alternative infection models providing comparable infor-
mation, and at the same time being easier to use and ethically
acceptable, would be highly useful. The fact that the immune sys-
tem of insects approximates early stages of mammalian defenses
upon infection has led to the use of insects, chiefly D. melano-
gaster, as surrogate hosts. Within the field of infection biology, the
larva of the wax moth G. mellonella is emerging as an attractive
infection model for human pathogens.
In this study, we provide evidence demonstrating thatK. pneu-
moniae infection of G. mellonella models some of the known fea-
tures of K. pneumoniae-triggered pneumonia. This infection pro-
cess is characterized by cellular necrosis as a result of a fierce
inflammatory response triggered by high bacterial burdens (57).
Likewise, infection of G. mellonella by K. pneumoniae resulted in
larval death due to bacterial replication in the hemolymph, in-
creased PO activity (at 12 h postinfection), which is a typical G.
mellonella response upon septic injury (45), and hemocyte deple-
tion. Moreover, differential immunostaining experiments re-
vealed that G. mellonella hemocytes did not engulf K. pneumoniae
52145. Similar observations were made by infecting human cell
cultures and mouse macrophages with this pathogen (35, 36, 51,
58). Strikingly, the G. mellonella model also recapitulates addi-
tional aspects of the interplay betweenK. pneumoniae and the lung
innate immune system. Mounting evidence indicates that activa-
tion of early inflammatory responses is essential for clearing K.
pneumoniae infections (21–28), and augmentation of this protec-
tive immune response decreases the mortality associated with
Klebsiella infection (29–32). Similarly, we showed in this work
that an induced response composed of antimicrobial factors pro-
vided protection against subsequent infection by a lethal dose of
Klebsiella. Of particular interest, we found that the antimicrobial
factors present in the hemolymph of preimmunized larvae killed
wild-type bacteria. Therefore, our findings demonstrating that
wild-type K. pneumoniae did not elicit the production of antimi-
crobial factors at early time points postinfection could be consid-
ered a strategy to survive in G. mellonella. Notably, we obtained
FIG 8 In vivomonitoring ofK. pneumoniae gene expression. Luminescence in
the hemolymph of infected larvae was determined at different time points
postinfection (five larvae per time point) and corrected by the number of CFU.
Larvae were infected with K. pneumoniae 52145 carrying the transcriptional
fusion cps::lucFF (A), pmrH::lucFF (B), pagP::lucFF (C), or lpxO::lucFF (D).
Results are expressed as fold increases from the luminescence per CFU of the
inoculum. Luminescence in the hemolymph of infected larvae was determined
at 5 h postinfection (E, F, and G) or 1 h postinfection (H) (five larvae per time
point) and corrected by the number of CFU. Larvae were infected with K.
pneumoniae 52145 (WT), 52145 phoQGB (phoQ), 52145 pmrAB (pmrAB),
52145 pmrAB phoQGB (phoQ-pmrAB), or 52145 rcsB (rcsB) carrying the
transcriptional fusion cps::lucFF (E), pmrH::lucFF (F), pagP::lucFF (G), or
lpxO::lucFF (H). Results are expressed as percentages of the luminescence per
CFU of K. pneumoniae 52145. *, results are significantly different (P  0.05;
one-tailed t test) from the results for K. pneumoniae 52145.
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similar results in human cell models and mice and in tests of K.
pneumoniae susceptibility to antimicrobial factors upregulated
during pneumonia (34, 54). On the whole, our data support the
notion that K. pneumoniae employs conceptually similar subver-
sion strategies in both the lung and G. mellonella innate immune
systems to create a niche favorable for replication. Further studies
are warranted to decipher whetherK. pneumoniae targets the same
host determinants in G. mellonella and mammalian models (34,
59, 60). Nonetheless, to address this question rigorously, further
advances in our knowledge of G. mellonella cell biology are
needed.
Another important finding of our study is that theG.mellonella
model is useful for assessing the virulence potential of K. pneu-
moniae. It is becoming evident that there are differences in the
virulence potential of K. pneumoniae strains (61–63). Our data
revealed that the G. mellonella model discriminates strains re-
garded as highly virulent from others considered less virulent, and
even pinpoints differences among highly virulent strains. To ex-
plain these differences, a systematic comparison of the genome
features of strains together with an analysis of virulence features of
these isolates in mammalian models should be carried out. Note
that the genome sequences of K. pneumoniae 43816 and 52145 are
not yet available. Nevertheless, our findings support the notion
that the G. mellonella model is an easy-to-handle system for com-
paring the virulence of different K. pneumoniae isolates or Kleb-
siella species. Furthermore, in this work we found that K. pneu-
moniae mutants previously known to be attenuated in the mouse
pneumonia model were also attenuated in the G. mellonella
model. In further support of the hypothesis that prevention of
host responses is an important feature of K. pneumoniae patho-
genesis, we found that all mutants activated G. mellonella defen-
sive responses. Moreover, this was also true for the lpxO mutant,
for which there was no previous information on its possible con-
tribution toK. pneumoniae virulence. Studies are ongoing to char-
acterize in depth the contribution of LpxO-dependent lipid A
modification to K. pneumoniae virulence.
The G. mellonella model also allowed us to monitor K. pneu-
moniae gene expression. We found that the expression levels of cps
and the loci implicated in lipid A remodeling peaked during the
first hours postinfection, further emphasizing the importance of
these determinants for K. pneumoniae survival in G.mellonella. At
present, we can only speculate on which signal(s) within the he-
molymph of infected larvae is sensed by Klebsiella to upregulate
gene expression. However, since antimicrobial peptides upregu-
late the expression of these loci in vitro (54), it is tempting to
speculate that G. mellonella antimicrobial factors may represent
this in vivo signal. In support of this hypothesis, we found that the
PhoPQ and PmrAB two-component systems, which control anti-
microbial peptide-induced transcriptional changes in vitro (54),
also governed the expression of cps and the loci implicated in lipid
A remodeling inG.mellonella. Although our data indicate that the
Rcs system does not contribute to the expression of these loci inG.
mellonella, it is evident that Rcs-controlled systems are needed for
K. pneumoniae survival in G. mellonella, since the rcsB mutant is
attenuated.
Despite the clear utility of G. mellonella as a surrogate host for
assessing infections with K. pneumoniae, it is worth commenting
on the limitations of the G. mellonella model. The processes that
are reproduced in mice and G. mellonella may represent ancient
mechanisms of pathogen interaction with the innate immune sys-
tem. However, the evolutionary distance between these models
also makes it clear that many host-specific phenomena are likely to
exist. Further impediments are the reduced knowledge about the
G. mellonella immune gene repertoire, cell death pathways, and
hemocyte biology and the nonexistence of a well-established
method to generateG.mellonellamutants. Advances in these areas
will facilitate three-dimensional analysis of host-pathogen inter-
actions, i.e., testing a panel ofG.mellonellamutants versus a panel
of bacterial mutants over time.
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